Sangamo Therapeutics, Inc. (SGMO)
OTCMKTS · Delayed Price · Currency is USD
0.1800
+0.0400 (28.57%)
May 4, 2026, 3:59 PM EST
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $46.15 million as of May 6, 2026. Its market cap has decreased by -72.10% in one year.
Market Cap
46.15M
Enterprise Value
52.00M
Revenue
39.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.18
Market Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from 92.36M to 46.15M, a decrease of -50.03%. That is a compound annual growth rate of -2.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 46.15M | -67.35% |
| Dec 31, 2025 | 141.33M | -33.59% |
| Dec 31, 2024 | 212.82M | 120.88% |
| Dec 29, 2023 | 96.35M | -81.28% |
| Dec 30, 2022 | 514.58M | -52.90% |
| Dec 31, 2021 | 1.09B | -50.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 182.74M |
| Glorywin Entertainment Group | 149.60M |
| HST Global | 140.02M |
| NDT Pharmaceuticals | 114.12M |
| BioStem Technologies | 74.62M |
| Nuo Therapeutics | 58.08M |
| Cell Source | 57.07M |
| ProText Mobility | 54.51M |